Safety of sputum induction in asthmatics in clinical practice Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Safety and tolerability of single doses of AZD5069 in healthy volunteers Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
Safety and tolerability of multiple-dose indacaterol, a novel 24-hour β2 -agonist, in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 253s Year: 2005
Safety of sputum induction Source: Eur Respir J 2002; 20: 9S-18S Year: 2002
Evaluation of safety, tolerability, pharmacokinetics, and food effect of Danirixin oral tablets in Japanese elderly healthy subjects Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Safety of sputum induction in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Safety, tolerability and pharmacokinetics of AZD9668, an oral neutrophil elastase inhibitor, in healthy subjects and patients with COPD Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
Safety of once-daily QMF149 in patients with persistent asthma Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019
Design and implementation of a multi-part, flexible protocol to assess the tolerability and pharmacodynamic effects of PUR118 in healthy subjects and COPD patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Feasibility and safety of induced sputum in infants Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
Comparision of patient acceptability and clinical efficacy of different inhaler devices in asthmatics Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007
Dry powder inhaled ribavirin in healthy volunteers: safety, tolerability, lung and systemic pharmacokinetics Source: International Congress 2017 – From microbiology to clinical work Year: 2017
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002
Efficacy and tolerability of ciclesonide (CIC) in the treatment of 24,037 asthmatic patients in routine clinical care Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Safety, efficacy and pharmacokinetics of inhaled TPI 1020 in smokers with asthma Source: Annual Congress 2008 - New treatments for asthma Year: 2008
Safety, pharmacokinetics, and pharmacodynamics of TD-8236, an inhaled pan-JAK inhibitor, following single- and multiple-ascending doses in healthy volunteers and mild asthmatics Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence Year: 2021
Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008